跳转至内容
Merck
CN
  • hDNA2 nuclease/helicase promotes centromeric DNA replication and genome stability.

hDNA2 nuclease/helicase promotes centromeric DNA replication and genome stability.

The EMBO journal (2018-05-19)
Zhengke Li, Bochao Liu, Weiwei Jin, Xiwei Wu, Mian Zhou, Vincent Zewen Liu, Ajay Goel, Zhiyuan Shen, Li Zheng, Binghui Shen
摘要

DNA2 is a nuclease/helicase that is involved in Okazaki fragment maturation, replication fork processing, and end resection of DNA double-strand breaks. Similar such helicase activity for resolving secondary structures and structure-specific nuclease activity are needed during DNA replication to process the chromosome-specific higher order repeat units present in the centromeres of human chromosomes. Here, we show that DNA2 binds preferentially to centromeric DNA The nuclease and helicase activities of DNA2 are both essential for resolution of DNA structural obstacles to facilitate DNA replication fork movement. Loss of DNA2-mediated clean-up mechanisms impairs centromeric DNA replication and CENP-A deposition, leading to activation of the ATR DNA damage checkpoints at centromeric DNA regions and late-S/G2 cell cycle arrest. Cells that escape arrest show impaired metaphase plate formation and abnormal chromosomal segregation. Furthermore, the DNA2 inhibitor C5 mimics DNA2 knockout and synergistically kills cancer cells when combined with an ATR inhibitor. These findings provide mechanistic insights into how DNA2 supports replication of centromeric DNA and give further insights into new therapeutic strategies.

材料
产品编号
品牌
产品描述

DNA2 Inhibitor C5, ≥95% (HPLC)
Sigma-Aldrich
RO-3306, ≥98% (HPLC)
Supelco
4-羟基他莫西芬, analytical standard, (E) and (Z) isomers (50:50)